Xiamen Yanjan New Material Co., Ltd. (300658.SZ)
Xiamen, CN
Xiamen Yanjan New Material Co., Ltd. functions as a key supplier of specialized components for the disposable personal care industry, operating across China and on a global scale. The company's offerings include PE perforated films, 3D aperture non-woven fabrics, hot air through non-wovens, and ADL surge layers. These vital materials are primarily incorporated into products such as sanitary napkins, absorbent pads, and both infant and adult diapers. Additionally, their products find utility in the medical treatment and food packaging sectors. Established in 2000, Xiamen Yanjan New Material Co., Ltd. maintains its principal office in Xiamen, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.25% | -7.36% | -44.36% | -44.97% | +1.00% | -18.42% | +95.95% | +82.35% | +12.47% | -2.66% | -2.66% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-02 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+17.4% ★ Q1'26: +9.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+50.0% ★ Q1'26: +186.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.5% Q1'26: +12.5% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+6.5% Q1'26: +10.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+5.2% Q1'26: +8.6% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-3.8% ★ Q1'26: -1.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×4.37× Q1'26: 3.34× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
738.15M
est: 738.00M (+0.0%)
|
766.27M
est: 727.00M (+5.4%)
|
1.04B
est: 852.00M (+21.8%)
|
1.59B
est: 1.27B (+24.7%)
|
1.27B
est.
|
1.25B
est: 1.39B (-9.8%)
|
1.26B
est: 1.82B (-30.9%)
|
1.23B
est: 1.82B (-32.4%)
|
1.48B
est: 2.21B (-32.7%)
|
1.74B
est: 2.66B (-34.4%)
|
2.21B
2.21B – 2.21B
-17.0% YoY
|
2.66B
2.66B – 2.66B
+20.5% YoY
|
| EBITDA |
141.04M
est: 118.26M (+19.3%)
|
90.26M
est: 116.50M (-22.5%)
|
160.20M
est: 136.53M (+17.3%)
|
446.10M
est: 203.84M (+118.8%)
|
203.04M
est.
|
135.97M
est: 222.91M (-39.0%)
|
163.49M
est: 291.74M (-44.0%)
|
139.64M
est: 291.74M (-52.1%)
|
177.87M
est: 268.64M (-33.8%)
|
239.79M
est: 323.71M (-25.9%)
|
268.64M
268.64M – 268.64M
-17.0% YoY
|
323.71M
323.71M – 323.71M
+20.5% YoY
|
| EBIT |
119.23M
est: 62.68M (+90.2%)
|
62.71M
est: 61.75M (+1.6%)
|
120.34M
est: 72.37M (+66.3%)
|
385.73M
est: 108.04M (+257.0%)
|
107.62M
est.
|
58.85M
est: 118.15M (-50.2%)
|
64.12M
est: 154.64M (-58.5%)
|
57.89M
est: 154.64M (-62.6%)
|
67.09M
est: 112.59M (-40.4%)
|
113.67M
est: 135.67M (-16.2%)
|
112.59M
112.59M – 112.59M
-17.0% YoY
|
135.67M
135.67M – 135.67M
+20.5% YoY
|
| Net Income |
90.13M
est: 109.33M (-17.6%)
|
48.61M
est: 76.53M (-36.5%)
|
82.31M
est: 86.25M (-4.6%)
|
299.51M
est: 215.03M (+39.3%)
|
151.25M
est.
|
18.08M
est: 169.47M (-89.3%)
|
20.87M
est: 54.12M (-61.4%)
|
29.38M
est: 54.12M (-45.7%)
|
27.28M
est: 127.92M (-78.7%)
|
40.52M
est: 193.52M (-79.1%)
|
127.92M
127.92M – 127.92M
-33.9% YoY
|
193.52M
193.52M – 193.52M
+51.3% YoY
|
| SGA |
102.31M
est: 33.34M (+206.9%)
|
132.07M
est: 32.84M (+302.1%)
|
175.76M
est: 38.49M (+356.6%)
|
118.73M
est: 57.47M (+106.6%)
|
57.24M
est.
|
118.25M
est: 62.84M (+88.2%)
|
108.35M
est: 82.25M (+31.7%)
|
103.67M
est: 82.25M (+26.0%)
|
126.57M
est: 188.15M (-32.7%)
|
133.85M
est: 226.72M (-41.0%)
|
188.15M
188.15M – 188.15M
-17.0% YoY
|
226.72M
226.72M – 226.72M
+20.5% YoY
|
| EPS |
0.37
est: 0.33 (+11.0%)
|
0.18
est: 0.23 (-22.9%)
|
0.30
est: 0.26 (+14.1%)
|
1.11
est: 0.66 (+69.3%)
|
0.46
est.
|
0.07
est: 0.52 (-87.1%)
|
0.06
est: 0.17 (-63.6%)
|
0.10
est: 0.17 (-39.4%)
|
0.08
est: 0.39 (-79.5%)
|
0.12
est: 0.59 (-79.7%)
|
0.39
0.39 – 0.39
-33.9% YoY
|
0.59
0.59 – 0.59
+51.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Denghuai Tuo | Deputy General Manager | — | male |
| Heping Fang | Executive Deputy GM & Director | — | male |
| Jing Kou | Deputy General Manager | — | female |
| Jiquan Xie | GM & Vice Chairman | — | male |
| Teng Huang | Chief Financial Officer, Company Secretary & Director | — | male |
| Yingqiu Xie | Deputy GM & Director | — | female |
| Zhong Wen Kang | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300658.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
